These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24511554)

  • 21. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z; Chen CX
    Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DMP-1 attenuates oxidative stress and inhibits TGF-β activation in rats with diabetic kidney disease.
    Du N; Liu S; Cui C; Zhang M; Jia J; Cao X
    Ren Fail; 2017 Nov; 39(1):229-235. PubMed ID: 27876428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The downregulation of SnoN expression in human renal proximal tubule epithelial cells under high-glucose conditions is mediated by an increase in Smurf2 expression through TGF-β1 signaling.
    Li X; Diao Z; Ding J; Liu R; Wang L; Huang W; Liu W
    Int J Mol Med; 2016 Feb; 37(2):415-22. PubMed ID: 26743567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emodin ameliorates renal fibrosis in rats via TGF-β1/Smad signaling pathway and function study of Smurf 2.
    Ma L; Li H; Zhang S; Xiong X; Chen K; Jiang P; Jiang K; Deng G
    Int Urol Nephrol; 2018 Feb; 50(2):373-382. PubMed ID: 29230704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy.
    Zeng W; Qi W; Mu J; Wei Y; Yang LL; Zhang Q; Wu Q; Tang JY; Feng B
    Sci Rep; 2019 Feb; 9(1):2049. PubMed ID: 30765727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
    Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P
    PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dencichine ameliorates kidney injury in induced type II diabetic nephropathy via the TGF-β/Smad signalling pathway.
    Jie L; Pengcheng Q; Qiaoyan H; Linlin B; Meng Z; Fang W; Min J; Li Y; Ya Z; Qian Y; Siwang W
    Eur J Pharmacol; 2017 Oct; 812():196-205. PubMed ID: 28633927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of astragalus injection on the TGFβ/Smad pathway in the kidney in type 2 diabetic mice.
    Nie Y; Li S; Yi Y; Su W; Chai X; Jia D; Wang Q
    BMC Complement Altern Med; 2014 May; 14():148. PubMed ID: 24885228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Smad7 and Smad ubiquitin regulatory factor 2 in a rat model of chronic pancreatitis.
    Hou XJ; Jin ZD; Jiang F; Zhu JW; Li ZS
    J Dig Dis; 2015 Jul; 16(7):408-15. PubMed ID: 25943897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.
    Lang H; Dai C
    Arch Med Res; 2016 Feb; 47(2):71-7. PubMed ID: 27018336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Smad ubiquitin regulatory factor 2 suppresses transforming growth factor-β mediated liver fibrosis.
    Cai Y; Zhou CH; Fu D; Shen XZ
    J Dig Dis; 2012 Jun; 13(6):327-34. PubMed ID: 22624557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pterostilbene Ameliorates Nephropathy Injury in Streptozotocin-Induced Diabetic Rats.
    Zhang Y; Ren S; Ji Y; Liang Y
    Pharmacology; 2019; 104(1-2):71-80. PubMed ID: 31117104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.
    Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY
    Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel reno-protective mechanism of Aspirin involves H2AK119 monoubiquitination and Set7 in preventing type 1 diabetic nephropathy.
    Goru SK; Gaikwad AB
    Pharmacol Rep; 2018 Jun; 70(3):497-502. PubMed ID: 29656179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
    Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artemisinin attenuates early renal damage on diabetic nephropathy rats through suppressing TGF-β1 regulator and activating the Nrf2 signaling pathway.
    Zhang H; Qi S; Song Y; Ling C
    Life Sci; 2020 Sep; 256():117966. PubMed ID: 32535079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel formula from mulberry leaf ameliorates diabetic nephropathy in rats via inhibiting the TGF-β1 pathway.
    Zhang Q; Lu Y; Ma Z; Li Y; Guo J; Meng Q; Bian H
    Food Funct; 2015 Oct; 6(10):3307-15. PubMed ID: 26242486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of sericine on TGF-beta1/Smad3 signal pathway of diabetic mephropathy rats kidney].
    Song CJ; Fu XM; Li J; Chen ZH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Feb; 27(1):102-5. PubMed ID: 21560355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.